Jun 30, 2012

Neurocrine Biosciences Q2 2012 Earnings Report

Total Revenue
$10.6M
Previous year: $12.2M
-13.1%
EPS
-$0.01
Previous year: $0.04
-125.0%
Gross Profit
$10.6M
Previous year: $12.2M
-13.1%
Cash and Equivalents
$42M
Previous year: $18.8M
+123.0%
Free Cash Flow
-$7.07M
Previous year: -$6.04M
+17.1%
Total Assets
$202M
Previous year: $127M
+58.6%

Neurocrine Biosciences

Neurocrine Biosciences